BR0208939A - Método e agente para tratamento oftálmikco tópico de doenças inflamatórias oculares - Google Patents
Método e agente para tratamento oftálmikco tópico de doenças inflamatórias ocularesInfo
- Publication number
- BR0208939A BR0208939A BR0208939-4A BR0208939A BR0208939A BR 0208939 A BR0208939 A BR 0208939A BR 0208939 A BR0208939 A BR 0208939A BR 0208939 A BR0208939 A BR 0208939A
- Authority
- BR
- Brazil
- Prior art keywords
- agent
- inflammatory
- present
- topical ophthalmic
- ophthalmic treatment
- Prior art date
Links
- 208000030533 eye disease Diseases 0.000 title abstract 4
- 230000002757 inflammatory effect Effects 0.000 title abstract 4
- 230000000699 topical effect Effects 0.000 title abstract 4
- 238000000034 method Methods 0.000 title abstract 2
- 239000003795 chemical substances by application Substances 0.000 abstract 7
- 229940121363 anti-inflammatory agent Drugs 0.000 abstract 2
- 239000002260 anti-inflammatory agent Substances 0.000 abstract 2
- 230000000694 effects Effects 0.000 abstract 2
- 150000003431 steroids Chemical class 0.000 abstract 2
- 108010036941 Cyclosporins Proteins 0.000 abstract 1
- 206010030113 Oedema Diseases 0.000 abstract 1
- 208000003251 Pruritus Diseases 0.000 abstract 1
- 208000025865 Ulcer Diseases 0.000 abstract 1
- 239000004480 active ingredient Substances 0.000 abstract 1
- 230000003110 anti-inflammatory effect Effects 0.000 abstract 1
- 150000001875 compounds Chemical class 0.000 abstract 1
- 229930182912 cyclosporin Natural products 0.000 abstract 1
- 208000027866 inflammatory disease Diseases 0.000 abstract 1
- 230000007803 itching Effects 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
- 208000024891 symptom Diseases 0.000 abstract 1
- 231100000397 ulcer Toxicity 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
- A61K31/407—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with other heterocyclic ring systems, e.g. ketorolac, physostigmine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/445—Non condensed piperidines, e.g. piperocaine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
- A61K31/4738—Quinolines; Isoquinolines ortho- or peri-condensed with heterocyclic ring systems
- A61K31/4745—Quinolines; Isoquinolines ortho- or peri-condensed with heterocyclic ring systems condensed with ring systems having nitrogen as a ring hetero atom, e.g. phenantrolines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A61P27/14—Decongestants or antiallergics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US28316901P | 2001-04-12 | 2001-04-12 | |
| PCT/JP2002/003664 WO2002085359A1 (en) | 2001-04-12 | 2002-04-12 | Agent for topical ophthalmic treatment of ocular inflammatory diseases |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| BR0208939A true BR0208939A (pt) | 2004-04-20 |
Family
ID=23084835
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| BR0208939-4A BR0208939A (pt) | 2001-04-12 | 2002-04-12 | Método e agente para tratamento oftálmikco tópico de doenças inflamatórias oculares |
Country Status (12)
Families Citing this family (17)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| NZ530845A (en) * | 2001-07-06 | 2006-03-31 | Sucampo Ag | Composition for topical administration |
| US20050043286A1 (en) * | 2001-11-19 | 2005-02-24 | Mario Fsadni | Use of an ascomycin for the treatment of blepharitis |
| EP1536793A1 (en) * | 2002-08-09 | 2005-06-08 | Sucampo Pharmaceuticals, Inc. | Pharmaceutical compositions comprising fk506 derivatives and the ir use for the treatment of allergic diseases |
| US7354574B2 (en) | 2002-11-07 | 2008-04-08 | Advanced Ocular Systems Limited | Treatment of ocular disease |
| US20040198763A1 (en) * | 2003-01-16 | 2004-10-07 | Sucampo Ag | Method of treating dry eye with a macrolide compound |
| US7220422B2 (en) * | 2003-05-20 | 2007-05-22 | Allergan, Inc. | Methods and compositions for treating eye disorders |
| US7083802B2 (en) | 2003-07-31 | 2006-08-01 | Advanced Ocular Systems Limited | Treatment of ocular disease |
| US7087237B2 (en) | 2003-09-19 | 2006-08-08 | Advanced Ocular Systems Limited | Ocular solutions |
| US7083803B2 (en) | 2003-09-19 | 2006-08-01 | Advanced Ocular Systems Limited | Ocular solutions |
| BRPI0608152A2 (pt) | 2005-02-09 | 2009-11-10 | Macusight Inc | formulações para tratamento ocular |
| US8663639B2 (en) | 2005-02-09 | 2014-03-04 | Santen Pharmaceutical Co., Ltd. | Formulations for treating ocular diseases and conditions |
| WO2007092620A2 (en) | 2006-02-09 | 2007-08-16 | Macusight, Inc. | Stable formulations, and methods of their preparation and use |
| CA2645488C (en) * | 2006-03-23 | 2014-09-02 | Macusight, Inc. | Formulations comprising rapamycin and methods using same for vascular permeability-related diseases or conditions |
| US8536190B2 (en) * | 2007-01-30 | 2013-09-17 | Allergan, Inc. | Treating unwanted ocular conditions using an ascomycin macrolactam |
| US20170198026A1 (en) * | 2014-06-06 | 2017-07-13 | The Schepens Eye Research Institute, Inc. | Compositions And Methods For Treating Tumors And Immune Based Inflammatory Diseases |
| EP3721868B1 (en) * | 2015-01-26 | 2022-06-01 | Bausch & Lomb Incorporated | Ophthalmic suspension composition |
| KR101710412B1 (ko) | 2015-09-15 | 2017-02-27 | 인제대학교 산학협력단 | Ycg063을 유효성분으로 함유하는 염증성 안구질환 예방 또는 치료용 약학조성물 |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4894366A (en) * | 1984-12-03 | 1990-01-16 | Fujisawa Pharmaceutical Company, Ltd. | Tricyclo compounds, a process for their production and a pharmaceutical composition containing the same |
| DK0406791T3 (da) * | 1989-07-05 | 1995-03-27 | Fujisawa Pharmaceutical Co | Vandigt flydende præparat til ekstern anvendelse |
| DE69021833T2 (de) * | 1989-11-09 | 1996-03-21 | Sandoz Ag | Heteroatome enthaltende tricyclische Verbindungen. |
| IE65341B1 (en) * | 1990-11-08 | 1995-10-18 | Fujisawa Pharmaceutical Co | Suspensions containing tricyclic compounds |
| US5514686A (en) * | 1991-04-26 | 1996-05-07 | Fujisawa Pharmaceutical Co., Ltd. | Use of macrolide compounds for eye diseases |
| AR004480A1 (es) * | 1995-04-06 | 1998-12-16 | Amico Derin C D | Compuestos de ascomicina que poseen actividad antiinflamatoria, pro cedimiento para prepararlos, uso de dichos compuestos para preparar agentesfarmaceuticos y composiciones farmaceuticas que los incluyen |
-
2002
- 2002-04-11 AR ARP020101334A patent/AR033151A1/es not_active Application Discontinuation
- 2002-04-12 MX MXPA03009273A patent/MXPA03009273A/es unknown
- 2002-04-12 CN CNA028082001A patent/CN1503671A/zh active Pending
- 2002-04-12 EP EP02717124A patent/EP1379247A1/en not_active Withdrawn
- 2002-04-12 JP JP2002582932A patent/JP2004529928A/ja not_active Abandoned
- 2002-04-12 BR BR0208939-4A patent/BR0208939A/pt not_active IP Right Cessation
- 2002-04-12 US US10/120,515 patent/US20020187998A1/en not_active Abandoned
- 2002-04-12 WO PCT/JP2002/003664 patent/WO2002085359A1/en not_active Application Discontinuation
- 2002-04-12 NZ NZ529255A patent/NZ529255A/en unknown
- 2002-04-12 KR KR10-2003-7013323A patent/KR20040007494A/ko not_active Application Discontinuation
- 2002-04-12 CA CA002445508A patent/CA2445508A1/en not_active Abandoned
-
2003
- 2003-10-10 NO NO20034560A patent/NO20034560L/no not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| CA2445508A1 (en) | 2002-10-31 |
| NO20034560L (no) | 2003-12-09 |
| NZ529255A (en) | 2006-09-29 |
| EP1379247A1 (en) | 2004-01-14 |
| AR033151A1 (es) | 2003-12-03 |
| MXPA03009273A (es) | 2004-02-12 |
| WO2002085359A1 (en) | 2002-10-31 |
| US20020187998A1 (en) | 2002-12-12 |
| KR20040007494A (ko) | 2004-01-24 |
| CN1503671A (zh) | 2004-06-09 |
| JP2004529928A (ja) | 2004-09-30 |
| NO20034560D0 (no) | 2003-10-10 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| BR0208939A (pt) | Método e agente para tratamento oftálmikco tópico de doenças inflamatórias oculares | |
| CA2502437A1 (en) | Method and composition containing latanoprost for treating ocular hypertension and glaucoma | |
| RU94041223A (ru) | Средство для лечения мотонейроновых заболеваний | |
| BR0314943A (pt) | Inibidores da proteìna reguladora da condutância transmembrana da fibrose cìstica e usos destes | |
| KR890004691A (ko) | 안과 제제물용 방부 시스템 | |
| CA2384448C (en) | Method of treatment of seborrheic dermatitis | |
| BR9914419A (pt) | Terapia para melhoria da percepção | |
| ATE15596T1 (de) | Pharmazeutische mittel. | |
| Kumar et al. | Coal tar therapy in paimoplantar psoriasis: old wine in an old bottle? | |
| US5270050A (en) | Paracetamol-based pharmaceutical composition | |
| CA2166704C (en) | Arsenic medicaments for the treatment of chronic fatigue syndrome | |
| CO4960654A1 (es) | Metodo para el tratamiento de enfermedades fisiologicas relacionadas con el uso o con las secuelas provocadas por el uso de la cocaina u otros estimulantes psicomotores | |
| BR9105185A (pt) | Formulacao farmaceutica e seus usos,e processo para o tratamento de hipercolesterolemia,hiperlipoproteinemia do tipo ii e desordens no comportamento sexual | |
| JP2002114686A (ja) | 点眼剤組成物 | |
| KR950031084A (ko) | 국소용 진양(鎭洋) 조성물 | |
| US6472381B1 (en) | Method of treating psoriasis | |
| KR950700067A (ko) | 3,5-디아미노-6-(2,3-디클로로페닐)-1,2,4-트리아진의 동통 및 부종 치료용 용도(use of 3,5-diamino-6-(2,3-dichlorophenyl)-1,2,4-triazine for the treatment of pain and oedema) | |
| KR970706816A (ko) | 알츠하이머 질환에서의 아밀로이드 베타A4형성을 감소시키는 〔R-(Z)〕-알파-(메톡시이미노)-알파-(1-아자비시클로-〔2. 2. 2〕옥트-3-일)아세토니트릴의 용도(Use of 〔R-(Z)〕-Alpha-(Methoxyimino)-Alpha-(1-Azabicyclo)〔2. 2. 2〕Oct-3-YI)Acetonitrile to Reduce Amyloid Beta A4 Formation in Alzheimer's Disease) | |
| BR9707303A (pt) | Agentes terapêuticos para asma | |
| BR0212077A (pt) | Compostos de aminopirróis como agentes antiinflamatórios | |
| US5681593A (en) | Method and composition for treating psoriasis, seborrheic dermatitis and eczema | |
| US5641781A (en) | Topical ophthalmic composition comprising a 2-[4-(azolylbutyl)piperazinylmethyl]benzimidazole derivative, in particular for the treatment of allergic conjunctivitis | |
| McCorriston | Hydrocortisone (compound F) acetate ointment in eczema of infants and children | |
| KR880009656A (ko) | 국소 치근막 질환의 치료 또는 예방법 | |
| Horiguchi et al. | Successful treatment with clonazepam for neuroleptic‐induced akathisia |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| B08F | Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette] |
Free format text: REFERENTE 5A., 6A., 7A. E 8A. ANUIDADES. |
|
| B08K | Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette] |
Free format text: REFERENTE AO DESPACHO 8.6 PUBLICADO NA RPI 2060 DE 29/06/2010. |